20 min listen
Wildcard: Moderna - A Case Study
FromIndustry Focus
ratings:
Length:
29 minutes
Released:
Jun 3, 2020
Format:
Podcast episode
Description
Moderna has gone from your standard biotech to one of the hot stocks of 2020 over the past few months as the company has worked on a COVID-19 vaccine. Shares are up around 200% since the pandemic hit, and the company has made some moves that seem odd on first pass. We use the company's dramatic rise and position as a clinical-stage business to explore insider selling, raising capital, and the business of biotechs. Stocks: MRNA Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter
Released:
Jun 3, 2020
Format:
Podcast episode
Titles in the series (100)
CG: What’s Next for the U.S. Grocery Industry?: It’s a time of major upheaval for the grocery business. Companies big and small are struggling with changing consumer demand. How to handle that was the main topic at GroceryShop, a trade show that brought the industry together taking place now in... by Industry Focus